Manufacturing challenges surround the use of IgM monoclonal antibodies, but these can be overcome with current technology.
Frank Hensel
Advertisement
Articles by Frank Hensel
Advertisement
Latest Updated Articles
Purification of IgM Monoclonal AntibodiesPublished: March 2nd 2008 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Implications of the First Liquid IV Infliximab Biosimilar
2
GSK Bets $50M on LTZ’s Immune-Engager Platform for Next-Gen Cancer Treatment
3
Risks, Resource Strain, and Trade-Offs in FDA’s CNPV Pilot Program
4
Why 503B Compounding Pharmacies Choose Prefabricated POD® Cleanrooms
5
